This white paper examines the impact of NAFLD and NASH as both a medical and economic crisis among military and civilian populations, and highlights the VA’s strategy to eradicate liver disease, including its broadened contract with Echosens to include the FibroScan mini+ portable technology
Having some fat in the liver is normal, but when fat accounts for more than five percent of the organ’s weight, it becomes dangerous.
Having some fat in the liver is normal, but when fat accounts for more than five percent of the organ’s weight, it becomes dangerous.
Studies show that liver disease accounts for approximately two million deaths per year worldwide, and with the growing twin epidemics of obesity and Type 2 diabetes mellitus, Non-Alcoholic Fatty Liver Disease (NAFLD) is expected to grow.
© 2019 echosens.